메뉴 건너뛰기




Volumn 18, Issue 2, 2006, Pages 174-179

Iron: Not a benign therapeutic drug

Author keywords

Deferoxamine; Iron poisoning; Treatment guidelines; Unit dose packaging

Indexed keywords

CARBONYL IRON; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; IRON; POLYVISOL;

EID: 33646496392     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000193275.62366.98     Document Type: Review
Times cited : (43)

References (16)
  • 1
    • 24044495580 scopus 로고    scopus 로고
    • 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
    • Watson WA, Litovitz TL, Rodgers GC Jr. et al. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589-666. This comprehensive report provides national statistics for toxic exposures in all age groups during 2004.
    • (2005) Am J Emerg Med , vol.23 , pp. 589-666
    • Watson, W.A.1    Litovitz, T.L.2    Rodgers Jr., G.C.3
  • 2
    • 0038678067 scopus 로고    scopus 로고
    • Iron poisoning in young children: Association with the birth of a sibling
    • Juurlink DN, Tenenbein M, Koren G, Redelmeier DA. Iron poisoning in young children: association with the birth of a sibling. Can Med Assoc J 2003; 168:1539-1542.
    • (2003) Can Med Assoc J , vol.168 , pp. 1539-1542
    • Juurlink, D.N.1    Tenenbein, M.2    Koren, G.3    Redelmeier, D.A.4
  • 4
    • 0035666707 scopus 로고    scopus 로고
    • Hepatotoxicity in acute iron poisoning
    • Tenenbein M. Hepatotoxicity in acute iron poisoning. Clin Toxicol 2001; 39:721-726.
    • (2001) Clin Toxicol , vol.39 , pp. 721-726
    • Tenenbein, M.1
  • 6
    • 0023549333 scopus 로고
    • High dose carbonyl iron for iron deficiency anemia: A randomized double blind trial
    • Gordeuk VR, Brittenham GM, Hughes MA, et al. High dose carbonyl iron for iron deficiency anemia: a randomized double blind trial. Am J Clin Nutr 1987; 46:1029-1034.
    • (1987) Am J Clin Nutr , vol.46 , pp. 1029-1034
    • Gordeuk, V.R.1    Brittenham, G.M.2    Hughes, M.A.3
  • 7
    • 26844465943 scopus 로고    scopus 로고
    • Iron ingestion: An evidence-based guideline for out-of-hospital management
    • Manoguerra AS, Erdman AR, Booze LL, et al. Iron ingestion: an evidence-based guideline for out-of-hospital management. Clin Toxicol 2005; 43:553-570. This article provides guidelines for the out-of-hospital management of iron exposures. An evidence-based expert and consensus process was used to create this guideline. This article provides a comprehensive review of many relevant articles on iron poisoning.
    • (2005) Clin Toxicol , vol.43 , pp. 553-570
    • Manoguerra, A.S.1    Erdman, A.R.2    Booze, L.L.3
  • 8
    • 0347513525 scopus 로고    scopus 로고
    • Acute iron poisoning: Clinical picture, intensive care needs, and outcome
    • Singhi SC, Baranwal AK. Acute iron poisoning: clinical picture, intensive care needs, and outcome. Indian Pediatr 2003; 40:1177-1182.
    • (2003) Indian Pediatr , vol.40 , pp. 1177-1182
    • Singhi, S.C.1    Baranwal, A.K.2
  • 9
    • 0019829099 scopus 로고
    • Emergency assessment of severity in iron overdose by clinical and laboratory methods
    • Lacouture PG, Wason S, Temple AR, et al. Emergency assessment of severity in iron overdose by clinical and laboratory methods. J Pediatr 1981; 99:89-91.
    • (1981) J Pediatr , vol.99 , pp. 89-91
    • Lacouture, P.G.1    Wason, S.2    Temple, A.R.3
  • 10
    • 0032961997 scopus 로고    scopus 로고
    • Usefulness of the total iron binding capacity in the evaluation and treatment of acute iron overdose
    • Siff JE, Meldon SW, Tomassoni AJ. Usefulness of the total iron binding capacity in the evaluation and treatment of acute iron overdose. Ann Emerg Med 1999; 33:73-76.
    • (1999) Ann Emerg Med , vol.33 , pp. 73-76
    • Siff, J.E.1    Meldon, S.W.2    Tomassoni, A.J.3
  • 11
    • 0026571807 scopus 로고
    • Pulmonary toxic effects of continuous deferrioxamine administration in acute iron poisoning
    • Tenenbein M, Kowalski S, Sienko A, et al. Pulmonary toxic effects of continuous deferrioxamine administration in acute iron poisoning. Lancet 1992; 339:699-701.
    • (1992) Lancet , vol.339 , pp. 699-701
    • Tenenbein, M.1    Kowalski, S.2    Sienko, A.3
  • 12
    • 0034141438 scopus 로고    scopus 로고
    • Intentional iron overdose in pregnancy: Management and outcome
    • Tran T, Wax JR, Philput C, et al. Intentional iron overdose in pregnancy: management and outcome. J Emerg Med 2000; 18:222-225.
    • (2000) J Emerg Med , vol.18 , pp. 222-225
    • Tran, T.1    Wax, J.R.2    Philput, C.3
  • 13
    • 0033969435 scopus 로고    scopus 로고
    • The efficacy of oral deferiprone in acute iron poisoning
    • Berkovitch M, Livne A, Lushkov G, et al. The efficacy of oral deferiprone in acute iron poisoning. Am J Emerg Med 2000; 18:36-40.
    • (2000) Am J Emerg Med , vol.18 , pp. 36-40
    • Berkovitch, M.1    Livne, A.2    Lushkov, G.3
  • 14
    • 0037089226 scopus 로고    scopus 로고
    • HBED ligand: Preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning
    • Bergeron PJ, Wiegand J, Brittenham GM. HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning. Blood 2002; 99:3019-3026.
    • (2002) Blood , vol.99 , pp. 3019-3026
    • Bergeron, P.J.1    Wiegand, J.2    Brittenham, G.M.3
  • 15
    • 20644437735 scopus 로고    scopus 로고
    • Unit-dose packaging of iron supplements and reduction of iron poisoning in young children
    • Tenenbein M. Unit-dose packaging of iron supplements and reduction of iron poisoning in young children. Arch Pediatr Adolesc Med 2005; 159:557-560. This is an excellent article demonstrating the effectiveness of unit-dose packaging of iron supplements as a primary prevention of iron poisoning and death.
    • (2005) Arch Pediatr Adolesc Med , vol.159 , pp. 557-560
    • Tenenbein, M.1
  • 16
    • 0142181027 scopus 로고    scopus 로고
    • HHS. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order
    • Food and Drug Administration. HHS. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order. Fed Regist 2003; 68:59714-59715.
    • (2003) Fed Regist , vol.68 , pp. 59714-59715


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.